Breaking barriers to expand RWE’s global potential and reach - Join IMS Health, the Department of Clinical Epidemiology Aarhus University Hospital, Denmark and the Unit of Clinical Epidemiology, Karolinska Institutet, Sweden, at the Scandinavian Real World Data Conference, Copenhagen, Nov. 20, 2015. To request your invitation please email OMiddagh@be.imshealth.com

1. Scandinavian data sources − a gold mine for
global RWE research
Friday, 20th November, 08.30−18.00, Hilton Copenhagen Airport Hotel
To request your invitation please email OMiddagh@be.imshealth.com
08.30−09.30: Registration in Hotel Lobby and coffee in Ballroom Foyer
Moderator
Clin. Assoc. Professor Mette Nørgaard, Head of Division of Clinical Quality, Department of
Clinical Epidemiology, Aarhus University Hospital, Denmark
09.30−09.40: Welcome address
Professor Lars Pedersen, Aarhus University Hospital and Professor Anders Ekbom, Karolinska
Institutet
09.40−09.50: Opening remarks “Scandinavia – an ideal environment for RWE research
offering access to unique data”
Associate Professor Patrik Sobocki, Senior Principal, Real-World Evidence Solutions, IMS Health
9.50−10.20: Data sources in Scandinavia and opportunities for RWE research
Professor Anders Ekbom, Karolinska Institutet
10.20−10.50: RWD and opportunities for research in Denmark
Professor Lars Pedersen, Aarhus University Hospital
10.50−11.10: Coffee Buffet, Ballroom Foyer
11.10−11.40: RWD and bio bank data in Norway
Christian Jonasson, Ph.D, Norwegian University of Science and Technology, Trondheim, Norway
11.40−12.10: RWD – Regulatory perspectives
Doris I. Stenver, Chief Medical Officer, Pharmacovigilance Risk Assessment Committee
Delegate, Danish Health and Medicines Authority Drug Safety Surveillance, Sundhedsstyrelsen
12.10−12.40: Uncertainty evidence generation and risk sharing
Niklas Hedberg, Chief Pharmacist, The Swedish Dental and Pharmaceutical Benefits Agency,
TLV
12.40−13.35: Lunch buffet, Horizon Restaurant
13.35−13.55: Amgen − Population-based epidemiological research in oncology
Justyna Amelio, Observational Research Scientist, Amgen, Uxbridge, UK
13.55−14.15: AstraZeneca – Pioneers in RWE research
Pål Hasvold, Medical Evidence Science Lead, Medical Department, AstraZeneca Nordic
Opportunities and needs in healthcare – case studies
14.15−14.45: Big C and big data: How to obtain RWE in cancer and link it to an expanding
amount of biological information
Associate Professor Nils Wilking MD PhD, Director, Department of Oncology and Radiation
Physics, Skåne University Hospital, Lund/Malmö
14.45−15.15: Changing COPD care
Professor Kjell Larsson, National Institute of Environmental Medicine, IMM, Karolinska Institutet
15.15−15.45: Afternoon Coffee Buffet, Ballroom Foyer
15.45−16.30: RCT vs. RWE and using Scandinavian RWD in a US context
Professor John P. A. Ioannidis, C. F. Rehnborg Professor in Disease Prevention in the School of
Medicine and Professor of Health Research and Policy (Epidemiology) and, by courtesy, of
Statistics, Stanford University, USA
16.30−17.00: Summary and closing remarks “The road ahead – suggestions and
comments from the speakers”
Professor Anders Ekbom and Associate Professor Patrik Sobocki
17.00−18.00: Reception in Ballroom Foyer
IMS Health Real-World Evidence Solutions
©2015 IMS Health Incorporated and its affiliates.
All rights reserved. Trademarks are registered in the United States and in various other countries.
Department of Medicine Solna
Clinical Epidemiology Unit
Conference Agenda